Avalyn Pharma Inc. Common Stock (AVLN) Stock Ticker
AVLN right now
Market factors today
Unlock the full AVLN picture
About Avalyn Pharma Inc. Common Stock
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
AVLN stock facts
| Ticker symbol | AVLN |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.2B |
| CEO | Lyn Baranowski |
| Employees | 55 |
| Headquarters | Boston, MA, US |
| IPO date | 2026-04-30 |
| Website | www.avalynpharma.com |
What you can see for AVLN on Tickr
Live AVLN price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the AVLN report.
Rankings
FAQ
What is the ticker symbol for Avalyn Pharma Inc. Common Stock?
The ticker symbol for Avalyn Pharma Inc. Common Stock is AVLN, listed on the NASDAQ Global Market.
What is AVLN?
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and…